Press Releases August 17, 2026 05:49 AM

ArcelorMittal statement regarding missile strike on its Ukraine plant

ArcelorMittal's Ukraine plant hit by missile strike causing casualties and operational disruption

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
MT

ArcelorMittal's Ukraine facility, ArcelorMittal Kryvyi Rih, was struck by a missile resulting in injuries to 13 employees, two fatalities, and damage to key production facilities. The event has partially halted operations as damage assessments and recovery planning are underway.

ArcelorMittal statement regarding missile strike on its Ukraine plant
MT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Missile strike injured 13 employees and caused two deaths at the Ukraine plant.
  • Main energy and blast furnace production facilities damaged, causing partial production halt.
  • ArcelorMittal is conducting damage assessments to determine restoration possibilities and timelines.

17 August 2026, 11:45 CET

ArcelorMittal can confirm that its Ukraine operation, ArcelorMittal Kryvih Rih, suffered a missile strike over the weekend in which 13 employees of the company and contractors were injured and tragically two employees died: one staff member and one from a contractor organization.

Our focus is on the families and loved ones of our colleagues who suffered from the attack. Those affected by the missile strike are receiving all necessary medical care in the city's medical facilities.

At the time of the attack, the plant was operational. However, as a result of the attack, the main production facilities of the energy and blast furnace production were damaged and the production processes of the plant were partially halted. Currently, relevant specialists are assessing the extent of the damage and the possibilities and timing of restoring operations.

Further updates will be provided in due course.

ENDS

About ArcelorMittal

ArcelorMittal is one of the world’s leading integrated steel and mining companies with a presence in 60 countries and primary steelmaking operations in 14 countries. It is the largest steel producer in Europe, among the largest in the Americas, and has a growing presence in Asia through its joint venture AM/NS India. ArcelorMittal sells its products to a diverse range of customers including the automotive, engineering, construction and machinery industries, and in 2025 generated revenues of $61.4 billion, produced 55.6 million metric tonnes of crude steel and 48.8 million tonnes of iron ore. Our purpose is to produce smarter steels for people and planet. Steels made using innovative processes which use less energy, emit significantly less carbon and reduce costs. Steels that are cleaner, stronger and reusable. Steels for the renewable energy infrastructure that will support societies as they transform through this century. With steel at our core, our inventive people and an entrepreneurial culture at heart, we will support the world in making that change.

ArcelorMittal is listed on the stock exchanges of New York (MT), Amsterdam (MT), Paris (MT), Luxembourg (MT) and on the Spanish stock exchanges of Barcelona, Bilbao, Madrid and Valencia (MTS). http://corporate.arcelormittal.com/  


ArcelorMittal Investor Relations contact informationGeneral +44 20 7543 1128 Retail +44 20 3214 2893 Bonds/Credit +33 157 955 035 


ArcelorMittal Corporate Communications contact informationPaul Weigh  Tel: +44 20 3214 2419 E-mailpress@arcelormittal.com 


Attachment

  • ArcelorMittal statement re missile strike on its Ukraine plant 17-08-2026 (SE)

Risks

  • Extended operational disruptions impacting steel production and supply chain due to plant damage.
  • Potential worsening of geopolitical tensions affecting investor confidence and regional operations.
  • Uncertainty in timing and cost of repairs could impact financial performance and project timelines.

More from Press Releases

Willis appoints Trevor Madden as Head of Captive and Insurance Management Solutions, Asia Pacific Sep 6, 2026 Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund Sep 6, 2026 Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026